Главная
Study mode:
on
1
Introduction
2
Overview
3
Key Concepts
4
Subclinical AF
5
Subclinical AF in pacemaker patients
6
Subclinical AF in nonpacing patients
7
Palm Springs analogy
8
Clinical trials
9
futility
10
Cryptogenic Stroke
11
Riva 15 vs Aspirin
12
Left atrial size
13
Arcadia trial
14
General AF screening
15
Burden of AF
16
Community Pharmacies
17
Stroke Stop
18
AF Screening
19
Screening vs Case Finding
20
Data
21
Sequential boundaries
22
Stroke Stop and Loop
23
Vital AF
24
Apple Heart Study
25
Big Impact
26
Heart Failure
27
Cognitive Impairment
28
Clinical Stroke
29
Atrial A appendage program
30
Risk factors
31
Clinical importance
32
Cost effectiveness
33
Bottom line results
34
Landmark analysis
35
Low risk medical population
36
High risk medical population
37
Stroke on treatment
38
Residual risk
39
Conclusions
40
Questions
41
exercise and AF
Description:
Join a comprehensive Grand Rounds lecture where Dr. Jeff Healey, Director of Arrhythmia Services at Hamilton Health Sciences and Associate Professor at McMaster University, explores critical aspects of atrial fibrillation (AF) screening and subclinical AF detection. Delve into key topics including subclinical AF in both pacemaker and non-pacing patients, cryptogenic stroke management, and the effectiveness of various screening approaches. Learn about significant clinical trials, including Stroke Stop and the Apple Heart Study, while understanding the relationships between AF and various health conditions such as heart failure, cognitive impairment, and clinical stroke. Examine the role of community pharmacies in AF screening, cost-effectiveness considerations, and risk stratification for different patient populations. Gain valuable insights into treatment outcomes, residual risk factors, and the latest developments in atrial appendage programs, concluding with a discussion on the connection between exercise and AF. Read more

Hot Topics in Atrial Fibrillation Screening and Subclinical AF

University of Ottawa Heart Institute
Add to list
0:00 / 0:00